Search
ISSN:
1756-8919
eISSN:
1756-8927
Disciplines
(Field of Science):
- biomedical engineering (Engineering and Technology)
- medical biology (Medical and Health Sciences )
- pharmacology and pharmacy (Medical and Health Sciences )
- medical sciences (Medical and Health Sciences )
- health sciences (Medical and Health Sciences )
- agriculture and horticulture (Agricultural sciences)
- biotechnology (Natural sciences)
- chemical sciences (Natural sciences)
(Field of Science)
Ministry points: Help
| Year | Points | List |
|---|---|---|
| Year 2024 | 100 | Ministry scored journals list 2024 |
| Year | Points | List |
|---|---|---|
| 2024 | 100 | Ministry scored journals list 2024 |
| 2023 | 100 | Ministry Scored Journals List |
| 2022 | 100 | Ministry Scored Journals List 2019-2022 |
| 2021 | 100 | Ministry Scored Journals List 2019-2022 |
| 2020 | 100 | Ministry Scored Journals List 2019-2022 |
| 2019 | 100 | Ministry Scored Journals List 2019-2022 |
| 2018 | 40 | A |
| 2017 | 40 | A |
| 2016 | 40 | A |
| 2015 | 40 | A |
| 2014 | 35 | A |
| 2013 | 30 | A |
| 2012 | 20 | A |
| 2011 | 20 | A |
Model:
Hybrid
Points CiteScore:
| Year | Points |
|---|---|
| Year 2023 | 5.8 |
| Year | Points |
|---|---|
| 2023 | 5.8 |
| 2022 | 6.5 |
| 2021 | 6.1 |
| 2020 | 5.2 |
| 2019 | 4.6 |
| 2018 | 5 |
| 2017 | 5.1 |
| 2016 | 4.8 |
| 2015 | 5.1 |
| 2014 | 5.4 |
| 2013 | 4.8 |
| 2012 | 3.7 |
| 2011 | 2.1 |
Impact Factor:
Log in to see the Impact Factor.
Sherpa Romeo:
Papers published in journal
Filters
total: 4
Catalog Journals
Year 2019
Year 2018
-
Comparative evaluation of new dihydropyrimidine and dihydropyridine derivatives perturbing mitotic spindle formation
Publication -
Matriptase-2: monitoring and inhibiting its proteolytic activity
Publication
Year 2012
-
Therapeutic intervention by the simultaneous inhibition of DNA repair and type I or type II DNA topoisomerases: one strategy, many outcomes
PublicationMany anticancer drugs reduce the integrity of DNA, forming strand breaks. This can cause mutations and cancer or cell death if the lesions are not repaired. Interestingly, DNA repair-deficient cancer cells (e.g., those with BRCA1/2 mutations) have been shown to exhibit increased sensitivity to chemotherapy. Based on this observation, a new therapeutic approach termed 'synthetic lethality' has been developed, in which radiation...
seen 540 times